Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
---|
01/31/2006 | US6992085 Octahydro-2H-pyrido[1,2-a]pyrazine compounds |
01/31/2006 | US6992077 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
01/31/2006 | CA2259345C Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents |
01/31/2006 | CA2208839C Quinuclidine derivatives and medicinal composition thereof |
01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
01/26/2006 | US20060019979 Method for the selective preparation of 3-oxo-4-aza-5a androstane compound |
01/26/2006 | DE10223908B4 Verfahren zur Herstellung von substituierten Pyridinen A process for the preparation of substituted pyridines |
01/26/2006 | CA2574625A1 Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester |
01/26/2006 | CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
01/26/2006 | CA2570800A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines |
01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
01/25/2006 | EP1617841A1 Amino cyclobutylamide modulators of chemokine receptor activity |
01/25/2006 | EP1490363B1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
01/25/2006 | EP1224189B1 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
01/25/2006 | CN1726214A Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
01/25/2006 | CN1726031A 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines |
01/25/2006 | CN1724537A Method of synthesizing methanesulfonic acid parzhushaxing intermedinte |
01/25/2006 | CN1724535A Production method of 9-nitro camptothecin |
01/24/2006 | US6989446 Reacting an aromatic carbonyl compound with carbon monoxide in presence of a metal catalyst |
01/24/2006 | US6989390 of carboxylic acids, such as maleic or glycolic acid; treating breast cancer, colon cancer, lung cancer, renal cancer and prostate cancer. |
01/19/2006 | WO2006006071A1 Resolution of an aryl-fused azapolycyclic compound |
01/19/2006 | US20060014964 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
01/19/2006 | US20060014957 Resolution of an aryl-fused azapolycyclic compound |
01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
01/18/2006 | EP1615894A2 3-azabicyclo 3.2.1 octane derivatives |
01/18/2006 | EP1615893A1 2-azabicyclo[3.3.1]nonane derivatives as opioid receptor antagonists |
01/17/2006 | US6986811 Perylene derivatives and their application as dispersants |
01/17/2006 | CA2300069C Naphthalimidobenzamide derivatives |
01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
01/12/2006 | US20060009481 Arylindenopyridines and related therapeutic and prophylactic methods |
01/12/2006 | US20060009480 Sinomenine and sinomenine compounds, synthesis and use |
01/12/2006 | CA2572350A1 Tetrahydroquinolines |
01/12/2006 | CA2572058A1 Azaindoles useful as inhibitors of protein kinases |
01/12/2006 | CA2571588A1 Pyrazolopyridine derivatives |
01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
01/11/2006 | EP1613601A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
01/11/2006 | EP1613322A2 Aminoquinoline compounds |
01/11/2006 | EP1613271A2 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
01/11/2006 | EP1442035B1 Process for the preparation of 4- (8-chloro-5, 6-dihydro-11h-benzo-[5,6]-cyclohepta-[1,2-b]-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) |
01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
01/11/2006 | EP0930883B1 Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain |
01/11/2006 | CN1720232A Tetandrine and tetrandrine compound, synthesis and application |
01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
01/11/2006 | CN1720228A Process for making risperidone and intermediates therefor |
01/11/2006 | CN1718579A Asparagic acid levo oxyfluorsaxin and its preparation method |
01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
01/11/2006 | CN1235882C Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application |
01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
01/05/2006 | WO2006000562A1 Process for the preparation of gabapentin |
01/05/2006 | CA2571058A1 Cannabinoid receptor ligands |
01/05/2006 | CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists |
01/05/2006 | CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
01/05/2006 | CA2568802A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
01/05/2006 | CA2567851A1 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
01/04/2006 | EP1395585B1 Antibacterial agents |
01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
01/04/2006 | EP0934288B1 Oxadiazoles, processes for their preparation and their use as medicaments |
01/04/2006 | CN1717392A Enantioselective alkylation of tricyclic compounds |
01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
01/04/2006 | CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
12/29/2005 | US20050288318 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics |
12/29/2005 | CA2569758A1 Extraction of alkaloids from opium |
12/28/2005 | EP1355650B1 Combination of active ingredients containing alfuzosine and apomorphine |
12/28/2005 | EP1129089B1 Spiro-indolines as y5 receptor antagonists |
12/28/2005 | EP1053238B1 Therapeutic compounds |
12/22/2005 | WO2005121095A1 Pyridine analogs as c5a antagonists |
12/22/2005 | WO2005121073A1 Inhibitors of histone deacetylase |
12/22/2005 | WO2005099702A3 R(-)-11-hydroxyaporphine derivatives and uses thereof |
12/22/2005 | US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
12/22/2005 | US20050282848 Synthesis and use of tetracyclic benzamide derivatives; antidiabetic agents; coupling isochromene anhydride with cyanobenzene compound and performing ring substitution reactions |
12/22/2005 | US20050282823 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
12/22/2005 | US20050282801 Novel phenantridine analogues and uses thereof |
12/22/2005 | US20050282787 Synthesis of tetracyclines and analogues thereof |
12/22/2005 | CA2569887A1 Pyrrolopyridine derivatives |
12/22/2005 | CA2569623A1 Novel compounds and use of tetrahydropyridothiophenes |
12/22/2005 | CA2568673A1 Pyridine analogs as c5a antagonists |
12/21/2005 | EP1607389A1 4-protected-amino-2-substituted-1,2,3,4-tetrahydroquinolines as intermediates for CETP inhibitors |
12/21/2005 | EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
12/20/2005 | US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
12/20/2005 | US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
12/20/2005 | CA2338206C High affinity ligands for nociceptin receptor orl-1 |
12/20/2005 | CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
12/15/2005 | WO2005119223A1 Compositions of matter useful as ph indicators and related methods |
12/15/2005 | WO2005118581A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors |
12/15/2005 | WO2005118543A1 Kinase inhibitor and use thereof |
12/15/2005 | WO2005118540A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
12/15/2005 | WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis |
12/15/2005 | US20050277660 Novel tetrahydroquinoline derivatives |
12/15/2005 | US20050277659 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists |
12/15/2005 | US20050277644 Pyridine analogs as C5a antagonists |
12/15/2005 | US20050277637 Arylindenopyridines and related therapeutic and prophylactic methods |
12/15/2005 | CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis |
12/15/2005 | CA2568163A1 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
12/15/2005 | CA2568159A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors |
12/14/2005 | EP1604663A1 Zolpidem Hemitartrate Form H Solvate |
12/14/2005 | EP1603568A2 Isoquinoline derivatives and methods of use thereof |
12/14/2005 | EP1603567A2 Tetracyclic benzamide derivatives and methods of use thereof |